Momenta Pharmaceuticals Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Momenta Pharmaceuticals Inc.

MNTA 52.48

0.0%

Oct 2 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: ghmm who wrote (2729)	1/25/2011 8:00:23 PM
From: Biomaven	Read Replies (2) of 3027

Any value for their FOB programs/technology in general? Yes, but I really can't say how much given how silent they have been on this. The fact that Novartis hasn't yet signed up for anything in the FOB area makes me more skeptical. I view M118 as having only negative expected value (they might easily be tempted to spend a bunch of money on it and it's clearly high risk). But the NPV of Copaxone is clearly a big number. I'm way less bullish than others on the chance for success in this program, but even with a 20% probability of success you get a significant expected value. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next